HMS Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $422K | Sell |
948
-122
| -11% | -$54.3K | 0.19% | 82 |
|
|
2025
Q1 | $508K | Buy |
1,070
+473
| +79% | +$224K | 0.28% | 63 |
|
|
2024
Q4 | $240K | Hold |
597
| – | – | 0.12% | 102 |
|
|
2024
Q3 | $278K | Hold |
597
| – | – | 0.14% | 97 |
|
|
2024
Q2 | $280K | Hold |
597
| – | – | 0.15% | 94 |
|
|
2024
Q1 | $250K | Hold |
597
| – | – | 0.14% | 98 |
|
|
2023
Q4 | $243K | Hold |
597
| – | – | 0.15% | 96 |
|
|
2023
Q3 | $208K | Hold |
597
| – | – | 0.14% | 106 |
|
|
2023
Q2 | $210K | Sell |
597
-155
| -21% | -$54.5K | 0.13% | 108 |
|
|
2023
Q1 | $237K | Hold |
752
| – | – | 0.15% | 102 |
|
|
2022
Q4 | $217K | Sell |
752
-20
| -3% | -$5.78K | 0.12% | 92 |
|
|
2022
Q3 | $224K | Hold |
772
| – | – | 0.14% | 110 |
|
|
2022
Q2 | $218K | Buy |
+772
| New | +$218K | 0.11% | 114 |
|
|
2021
Q3 | – | Sell |
-1,270
| Closed | -$256K | – | 134 |
|
|
2021
Q2 | $256K | Hold |
1,270
| – | – | 0.12% | 116 |
|
|
2021
Q1 | $273K | Hold |
1,270
| – | – | 0.12% | 107 |
|
|
2020
Q4 | $300K | Sell |
1,270
-4,294
| -77% | -$1.01M | 0.14% | 99 |
|
|
2020
Q3 | $1.51M | Sell |
5,564
-326
| -6% | -$88.7K | 0.59% | 31 |
|
|
2020
Q2 | $1.71M | Buy |
5,890
+4,888
| +488% | +$1.42M | 0.75% | 24 |
|
|
2020
Q1 | $238K | Hold |
1,002
| – | – | 0.23% | 72 |
|
|
2019
Q4 | $219K | Buy |
+1,002
| New | +$219K | 0.09% | 95 |
|
|
2019
Q3 | – | Sell |
-1,002
| Closed | -$184K | – | 194 |
|
|
2019
Q2 | $184K | Buy |
+1,002
| New | +$184K | 0.08% | 94 |
|
|
2019
Q1 | – | Sell |
-2,482
| Closed | -$411K | – | 119 |
|
|
2018
Q4 | $411K | Hold |
2,482
| – | – | 0.21% | 81 |
|
|
2018
Q3 | $478K | Hold |
2,482
| – | – | 0.24% | 86 |
|
|
2018
Q2 | $422K | Buy |
+2,482
| New | +$422K | 0.24% | 87 |
|